Skip to main content
Clinical Trials/CTRI/2023/01/049131
CTRI/2023/01/049131
Completed
未知

A comparative evaluation of efficacy and safety of Prednisolone acetate and Nepafenac eye drops in post-operative cataract surgery

Pt B D Sharma PGIMS Rohtak0 sites43 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: H269- Unspecified cataract
Sponsor
Pt B D Sharma PGIMS Rohtak
Enrollment
43
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients above 45 years of age with senile cataract undergoing phacoemulsification
  • 2\.Patients of either sex will be included
  • 3\.Patient willing to give written informed consent

Exclusion Criteria

  • 1\.Patients with presenile cataract, glaucoma, uveitis, complicated cataract, subluxated cataract, traumatic cataract or posterior segment pathology
  • 2\.Patients sensitive to aspirin and other related NSAIDs
  • 3\.Use of systemic or topical steroids within 2 weeks of surgery
  • 4\.Use of systemic or topical NSAIDs within 7 days of surgery
  • 5\.Patient with uncontrolled diabetes
  • 6\.Any intraoperative complication

Outcomes

Primary Outcomes

Not specified

Similar Trials